Reference
1. J. FW, J. LV, Hopkins C. ea. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. 2020.
2. Davies G, Lam M, Harris SE, et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. May 29 2018;9(1):2098.
3. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. Mar 2012;23:3 p preceding table of contents, 1-298.
4. J M Greve, G Davis, A M Meyer, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:839-947.
5. Sugrue RJ. Interactions between respiratory syncytial virus and the host cell: opportunities for antivirus strategies? Expert Rev Mol Med. Sep 5 2006;8(21):1-17.
6. van Cauwenberge P, Ingels K. Effects of viral and bacterial infection on nasal and sinus mucosa. Acta Otolaryngol. Mar 1996;116(2):316-321.
7. A Wanner, M Salathé, O’Riordan TG. Mucociliary clearance in the airways. American journal of respiratory and critical care medicine 1996;154:1868-1902.
8. Banks C, Freeman L, Cho DY, Woodworth BA. Acquired cystic fibrosis transmembrane conductance regulator dysfunction. World J Otorhinolaryngol Head Neck Surg. Sep 2018;4(3):193-199.
9. Cabrini G, Rimessi A, Borgatti M, et al. Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis. Front Immunol. 2020;11:1438.
10. J. FW, J. LV, Mullol J. ea. European position paper on rhinosinusitis and nasal polyps 2007. 2007.
11. Basharat U, Aiche MM, Kim MM, Sohal M, Chang EH. Are rhinoviruses implicated in the pathogenesis of sinusitis and chronic rhinosinusitis exacerbations? A comprehensive review. Int Forum Allergy Rhinol. Oct 2019;9(10):1159-1188.
12. Passariello C, Schippa S, Conti C, et al. Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes. Microbes Infect. Mar 2006;8(3):758-766.
13. Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.N Engl J Med. Aug 8 2002;347(6):401-407.
14. Yan Y, Tan KS, Li C, et al. Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro. J Allergy Clin Immunol. Jul 2016;138(1):276-281 e215.
15. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy. Jun 2005;4(3):273-279.
16. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. Mar 2013;13(3):159-175.
17. Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. Jun 2012;67(6):509-516.
18. Guo T, Ma H, Zhou Y. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma.PeerJ. 2019;7:e7313.
19. Nguyen TN, Do BH, Kitamura T, et al. Expression of Cl(-) channels/transporters in nasal polyps. Eur Arch Otorhinolaryngol.Aug 2020;277(8):2263-2270.
20. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. Jul-Aug 2016;4(4):565-572.
21. Woodworth BA. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency. Laryngoscope. Oct 2015;125 Suppl 7:S1-S13.
22. Guimbellot JS, Fortenberry JA, Siegal GP, et al. Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol. Nov 2008;39(5):514-521.
23. Huabin L, Yuting L, J W. Endotypes and precision medicine in chronic sinusitis reatment. J Otolaryngol Ophthalmol Shandong Univ. 2019;33:9-13.
24. Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. Nov 2016;138(5):1344-1353.
25. Zheng H, Tang L, Song B, et al. Inflammatory patterns of antrochoanal polyps in the pediatric age group. Allergy Asthma Clin Immunol. 2019;15:39.